A Longitudinal Biomarker for the Extent of Skin Disease in Patients with Diffuse Cutaneous Systemic Sclerosis

OBJECTIVE: The goal of this study was to define a pharmacodynamic biomarker based on gene expression in skin that would provide a biological measure of disease extent in patients with diffuse cutaneous systemic sclerosis (dcSSc) and that could be used to monitor skin disease longitudinally. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Rice, Lisa M., Ziemek, Jessica, Stratton, Eric A., McLaughlin, Sarah R., Padilla, Cristina M., Mathes, Allison L., Christmann, Romy B., Stifano, Giuseppina, Browning, Jeffrey L., Whitfield, Michael L., Spiera, Robert F., Gordon, Jessica K., Simms, Robert W., Zhang, Yuqing, Lafyatis, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522178/
https://ncbi.nlm.nih.gov/pubmed/26240058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39287
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados